The 4 bullish analyst ratings for Alimera Sciences suggest a positive outlook for the stock. The average price target of $8.0 indicates a potential upside from its current price of $2.28. This information is important for investors as it shows that analysts have a positive view on the stock, which could lead to an increase in its price in the short term.